Capital Insight Partners, LLC Novo Nordisk A S Transaction History

Capital Insight Partners, LLC

$565 Million
Q3 2024

A detailed history of Capital Insight Partners, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Capital Insight Partners, LLC holds 46,204 shares of NVO stock, worth $4.61 Million. This represents 0.97% of its overall portfolio holdings.

Number of Shares

46,204

Previous 44,275 4.36%

Holding current value

$4.61 Million

Previous $6.32 Million 12.95%

% of portfolio

0.97%

Previous 1.21%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 09, 2024	BUY	$119.07 - $145.42 $229,686 - $280,515	1,929 Added 4.36%	46,204 $5.5 Million
Q2 2024 Jul 24, 2024	SELL	$122.71 - $146.91 $138,539 - $165,861	-1,129 Reduced 2.49%	44,275 $6.32 Million
Q1 2024 Apr 16, 2024	BUY	$102.11 - $135.92 $68,822 - $91,610	674 Added 1.51%	45,404 $5.83 Million
Q4 2023 Jan 24, 2024	BUY	$87.78 - $105.45 $45,470 - $54,623	518 Added 1.17%	44,730 $4.63 Million
Q3 2023 Oct 30, 2023	BUY	$90.94 - $199.54 $2.1 Million - $4.61 Million	23,125 Added 109.66%	44,212 $4.02 Million
Q2 2023 Jul 21, 2023	SELL	$155.98 - $172.65 $32,131 - $35,565	-206 Reduced 0.97%	21,087 $3.41 Million
Q1 2023 Apr 27, 2023	BUY	$132.34 - $159.14 $72,522 - $87,208	548 Added 2.64%	21,293 $3.39 Million
Q4 2022 Feb 07, 2023	BUY	$102.55 - $135.33 $17,536 - $23,141	171 Added 0.83%	20,745 $2.81 Million
Q3 2022 Oct 20, 2022	BUY	$95.28 - $116.93 $82,036 - $100,676	861 Added 4.37%	20,574 $2.05 Million
Q2 2022 Jul 20, 2022	SELL	$103.24 - $121.81 $8,568 - $10,110	-83 Reduced 0.42%	19,713 $2.2 Million
Q1 2022 Apr 21, 2022	SELL	$93.1 - $112.54 $74,386 - $89,919	-799 Reduced 3.88%	19,796 $2.2 Million
Q4 2021 Jan 20, 2022	BUY	$95.88 - $117.08 $98,181 - $119,889	1,024 Added 5.23%	20,595 $2.31 Million
Q3 2021 Oct 13, 2021	BUY	$84.42 - $106.62 $54,450 - $68,769	645 Added 3.41%	19,571 $1.88 Million
Q2 2021 Aug 02, 2021	BUY	$67.66 - $84.76 $57,849 - $72,469	855 Added 4.73%	18,926 $1.59 Million
Q1 2021 Apr 20, 2021	BUY	$67.06 - $75.82 $29,841 - $33,739	445 Added 2.52%	18,071 $1.22 Million
Q4 2020 Feb 02, 2021	BUY	$63.89 - $73.8 $13,608 - $15,719	213 Added 1.22%	17,626 $1.23 Million
Q3 2020 Nov 04, 2020	SELL	$63.69 - $70.22 $19,043 - $20,995	-299 Reduced 1.69%	17,413 $1.21 Million
Q2 2020 Jul 15, 2020	SELL	$58.54 - $67.94 $4,566 - $5,299	-78 Reduced 0.44%	17,712 $1.16 Million
Q1 2020 Apr 14, 2020	BUY	$49.46 - $64.78 $44,266 - $57,978	895 Added 5.3%	17,790 $1.07 Million
Q4 2019 Jan 27, 2020	SELL	$49.86 - $58.26 $1,296 - $1,514	-26 Reduced 0.15%	16,895 $978,000
Q3 2019 Oct 09, 2019	SELL	$47.54 - $53.43 $6,085 - $6,839	-128 Reduced 0.75%	16,921 $875,000
Q2 2019 Jul 09, 2019	BUY	$46.79 - $52.47 $13,335 - $14,953	285 Added 1.7%	17,049 $870,000
Q1 2019 Apr 04, 2019	BUY	$46.36 - $52.63 $7,046 - $7,999	152 Added 0.92%	16,764 $877,000
Q4 2018 Jan 03, 2019	BUY	$41.54 - $47.25 $690,062 - $784,917	16,612 New	16,612 $765,000

Others Institutions Holding NVO

# of Institutions

1,953

Shares Held

320M

Call Options Held

5.49M

Put Options Held

7.78M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $225B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Insight Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Insight Partners, LLC with notifications on news.

Account

Capital Insight Partners, LLC Novo Nordisk A S Transaction History